Search Within

Mark Andrew Dickson

  1. "Sarcoma Surgeons"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (24)
Groups
  1. Department of Medicine (55)
  2. Sarcoma Service (55)
  3. Sarcoma Surgeons (55)
  4. Solid Tumor Oncology Division (55)
  5. Surgery (55)
  6. GSK Faculty (54)

More Groups

People
  1. Samuel Singer (51)
  2. William Tap (49)
  3. Mary Keohan (41)
  4. Sandra D'Angelo (40)
  5. Mrinal Gounder (39)
  6. Cristina Antonescu (38)

More People

Years
  1. 2024 (6)
  2. 2023 (4)
  3. 2022 (11)
  4. 2021 (3)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (9)
  3. Annals of Oncology (5)
  4. Nature Communications (4)
  5. JAMA Oncology (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (7)
  4. Nature Publishing Group (6)
  5. American Medical Association (2)
  6. Elsevier Inc. (2)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A high-content screen for C/EBPα expression identifies novel therapeutic agents in dedifferentiated liposarcoma
    Journal Article

    Angeles, C. V.; Velez, A.; Rios, J.; Laxa, B.; Shum, D.; Ruiz, P. D.; Shen, Y.; Ostrovnaya, I.; Gularte-Mérida, R.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
    Meeting Abstract

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
    Journal Article

    Lee, A.; Kang, J. J.; Bernstein, H.; Marqueen, K. E.; Neal, B.; Kelly, C. M.; Dickson, M. A.; Tsai, C. J.; Tap, W.; Singer, S.; more...
    Cancer Medicine (2021)

    Fulltext@MSK | Save
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Rb and p53-deficient myxofibrosarcoma and undifferentiated pleomorphic sarcoma require Skp2 for survival
    Journal Article

    Li, G. Z.; Okada, T.; Kim, Y. M.; Agaram, N. P.; Sanchez-Vega, F.; Shen, Y.; Tsubokawa, N.; Rios, J.; Martin, A. S.; Dickson, M. A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save